Works in Cancer Chemotherapy & Pharmacology, 2011, Vol 68, Issue 6
Results: 53
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Preclinical evaluation of the novel multi-targeted agent R1530.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1377, doi. 10.1007/s00280-011-1603-2
- By:
- Publication type:
- Article
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1397, doi. 10.1007/s00280-011-1612-1
- By:
- Publication type:
- Article
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1387, doi. 10.1007/s00280-011-1631-y
- By:
- Publication type:
- Article
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1405, doi. 10.1007/s00280-011-1632-x
- By:
- Publication type:
- Article
Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1413, doi. 10.1007/s00280-011-1628-6
- By:
- Publication type:
- Article
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1421, doi. 10.1007/s00280-011-1643-7
- By:
- Publication type:
- Article
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1431, doi. 10.1007/s00280-011-1601-4
- By:
- Publication type:
- Article
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1439, doi. 10.1007/s00280-011-1637-5
- By:
- Publication type:
- Article
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1449, doi. 10.1007/s00280-011-1641-9
- By:
- Publication type:
- Article
Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1459, doi. 10.1007/s00280-011-1640-x
- By:
- Publication type:
- Article
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1477, doi. 10.1007/s00280-011-1645-5
- By:
- Publication type:
- Article
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1469, doi. 10.1007/s00280-011-1623-y
- By:
- Publication type:
- Article
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1485, doi. 10.1007/s00280-011-1611-2
- By:
- Publication type:
- Article
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1497, doi. 10.1007/s00280-011-1642-8
- By:
- Publication type:
- Article
Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1507, doi. 10.1007/s00280-011-1635-7
- By:
- Publication type:
- Article
Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1517, doi. 10.1007/s00280-011-1647-3
- By:
- Publication type:
- Article
Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1529, doi. 10.1007/s00280-011-1650-8
- By:
- Publication type:
- Article
Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1537, doi. 10.1007/s00280-011-1658-0
- By:
- Publication type:
- Article
Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1547, doi. 10.1007/s00280-011-1656-2
- By:
- Publication type:
- Article
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1557, doi. 10.1007/s00280-011-1660-6
- By:
- Publication type:
- Article
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1565, doi. 10.1007/s00280-011-1639-3
- By:
- Publication type:
- Article
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1575, doi. 10.1007/s00280-011-1648-2
- By:
- Publication type:
- Article
Preclinical evaluation of the novel multi-targeted agent R1530.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1585, doi. 10.1007/s00280-011-1608-x
- By:
- Publication type:
- Article
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1595, doi. 10.1007/s00280-011-1657-1
- By:
- Publication type:
- Article
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1603, doi. 10.1007/s00280-011-1638-4
- By:
- Publication type:
- Article
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1611, doi. 10.1007/s00280-011-1661-5
- By:
- Publication type:
- Article
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1629, doi. 10.1007/s00280-011-1727-4
- By:
- Publication type:
- Article
Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbB.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1373, doi. 10.1007/s00280-011-1748-z
- By:
- Publication type:
- Article
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Report